|
COPCORD BHIGWAN
COMPLETES 10 YEARS
The WHO-ILAR (International League of Associations for Rheumatology)
COPCORD (Community Oriented program and control of Rheumatic
Diseases) has completed 10 successful years. COPCORD was meant
to target rural communities in developing countries using
low cost low infrastructure design. Begun in over 19 countries
Worldwide, India was the seventh country to initiate its maiden
COPCORD in village Bhigwan (Pune). And unlike every other
COPCORD which completed the initial population survey stage
only, the COPCORD Bhigwan was continued in a predetermined
planned manner to fulfill all the requirements of the parent
WHO program that is not only to measure the prevalence of
rheumatic symptoms and ailments but also to determine risk
factors, identify new cases and disease profiles, impart health
education to the community and recommend strategies for disease
control. Till date, the project has provided free of cost
diagnosis and treatment services to over 1100 patients in
Bhigwan and acquired community research data from a 9000 plus
population. COPCORD Bhigwan is the only program of its kind
to have provided treatment. As a goodwill measure, over 45,000
population residing in the neighboring 187 villages have been
allowed to seek free of cost advise on their arthritis ailments.
Having deviated in several ways and advocating a fast track
research design, the COPCORD Bhigwan model has been adopted
by several countries post 1996, and is the basis of an ongoing
development program for a future COPCORD. In a seminal WHO
technical research series publication (The Burden of Musculoskeletal
conditions at the start of the new millennium ; TRS 919, 2003),
the Bhigwan data on rheumatoid arthritis and knee osteoarthritis
was used to project the scenario in South East Asia.
Announcing this and much more, Dr Arvind Chopra, the chief
Bhigwan project investigator and currently the international
COPCORD co-ordinator, in a specially convened BJD (Bone and
Joint Decade) India activity week program in Bhigwan on 15
Oct 06 summed up the 10 year COPCORD trek by declaring three
key messages for the Government based on the Bhigwan COPCORD
experience (1) promote community health programs based on
partnership between expert private medical practitioner/specialists
and Gram Panchayat (2) train rural doctors adequately and
appropriately, irrespective of their academic qualifications,
so as to bring them into the fold of Govt health programs
(3)reduce the communication gap between the Government and
the public health consumer through sensible advocacy.
The meeting was addressed by several patients, health workers
and rural doctors to demonstrate the impact of the Bhigwan
project in reducing pain and suffering due to arthritis and
further improve quality of life. Almost a revolution to fight
arthritis and rheumatism had erupted in this small village
because of a tremendous gelling between the suffering community
and the caring project health care providers. A galaxy of
experts from Delhi (including ICMR & AIIMS), Calcutta, Bangalore,
Chennai, Hyderabad, Mumbai, Coimbatore, Lucknow, Aurangabad
and Pune (that included AFMC, BJ medical college, DY patil
Medical college, NIV, University of Pune) actively participated
to gather first hand information about this unique community
health model and answer queries from the large gathering of
villagers. Dr Mahendranath, Chairman BJD India and a renowned
rheumatologist from Bangalore, stated that the Bhigwan COPCORD
today had acquired international fame and had been accepted
and acclaimed, probably much more in the international arena
of Rheumatology. Dr Mahendranath announced an ambitious BJD
India sponsored research road map where-in the Bhigwan model
has been adopted to launch several similar population based
rheumatic musculoskeletal studies in Jammu, Chennai, Delhi,
Calcutta and Pune. Already, 20,000 population had already
completed the surveys. Prof Shubhada Jawdekar (HOD, Community
Medicine, BJ Medical College) declared that the Bhigwan COPCORD
was an outstanding example of a public- government partnership
wherein Dr Arvind Chopra a renowned practicing Pune Rheumatologist
had expertly and compassionately combined his skills with
that of the Bhigwan Gram Panchayat, a Govt functionary, to
create an exemplary community model. Prof S L Jadhav (HOD,
Community Medicne, DY patil Medical college) and several experts
from similar medical institutions and government bodies described
Dr Chopra and his Bhigwan model as a real practical field
expression of an otherwise theoretical class room teaching
and routine work that unfortunately continues to be the focus
of community health and medicine in the current Indian perspective,
more so in the Govt sector.
Dr HS Tandale, the Bhigwan COPCORD co-ordinator and a senior
retired PHC medical officer, narrated the key milestones of
the project especially the fact that several international
experts had visited Bhigwan to ascertain facts. Dr Tandale,
despite his age and failing health, had worked tirelessly
and was the real force behind the success of COPCORD Bhigwan,
declared Dr Chopra. Sh Ramesh Jadhav, a renowned local politician,
bravely asserted that any community and village would go out
of the way to co-operate and work with programs like COPCORD
Bhigwan and dedicated caring doctors like Dr Chopra. He further
said that projects like this need urgent recognition from
Government and should be adopted as the model for large scale
use to serve community and acquire useful data. In 1996, when
COPCORD Bhigwan was begun Sh Ramesh Jadhav as the Sarpanch
had provided excellent administrative and logistics support
. Sh R Jadhav had continued to be the dominant supporter of
the Bhigwan project till date, said Dr Chopra.
The annual MAI magazine focused on osteoarthritis, and edited
by Dr Kalindi Phadke, was distributed to all. MAI (Mission
Arthritis India) is a Pune based patient support group and
one of the founders of BJD India.
The Bhigwan program was chiefly organized by BJD India and
CRD, Pune. These programs also received significant sponsorship
and contributions from Arthritis Research & Care Foundation,
Pune, and Unichem Pharmaceutical and were co-ordinated and
conducted by Ms V Anuradha and Ms Manjit Saluja from Center
for Rheumatic Diseases (CRD), Pune.
|